col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


50 Ergebisse       Seite 1

 [1] 
SAGE Publications: International Journal of Immunopathology and Pharmacology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Dez―24 COVID-19: A threat to the respiratory system Ghulam Rasool, Waqas Ahmed Khan, Arif Muhammad Khan, Muhammad Riaz, Mazhar Abbas, Aziz ur Rehman, et al. (+2)
2 [GO] 2024―Dez―19 Use of CRP/lymphocyte ratio as a predictor of treatment selection and mortality in COVID-19 patients in the intensive care unit Efraim Guzel, Burak Mete, Oya Baydar Toprak, Nazire Ates Ayhan, Ahmet Firat, Yurdaer Bulut, et al. (+3)
3 [GO] 2024―Sep―07 Implication of IL-12A, IL-12B, IL-6, and TNF single-nucleotide polymorphisms in severity and susceptibility to COVID-19 R. Benmansour, M. R. Tagajdid, I. A Lahlou, H. Oumzil, H. El Hamzaoui, S. Fjouji, et al. (+10)
4 [GO] 2024―Jul―25 Prevalence of cutaneous manifestations and myositis-specific antibodies in COVID-19 patients and Anti-PL7 antibodies association with pulmonary radiological severity: A retrospective study Giorgio Alberto Oddenino, Paola Canepa, Emanuele Cozzani, Giulia Gasparini, Alessandro Garlaschi, Luca Roccatagliata, et al. (+2)
5 [GO] 2024―Jun―18 Is preexisting inflamed jaw marrow a “hidden” co-morbidity affecting outcomes of COVID-19 infections? - Clinical comparative study Johann Lechner, Robert E McMahon, Jerry E Bouquot, Florian Notter, Fabian Schick
6 [GO] 2024―Jun―05 Pre-pandemic antibodies screening against SARS-CoV-2 and virus detection among children diagnosed with eruptive fevers Nouhaila Najimi, Latifa Tajount, Zakia Regragui, Chaimae Remz, Rokaya Ait-Lhaj-Mhand, Chaimae Kadi, et al. (+6)
7 [GO] 2024―Mai―18 TYK2, IFITM3, IFNAR2 and OAS3 single-nucleotide polymorphisms among severe COVID-19 ICU patients in Morocco R. Benmansour, M. R. Tagajdid, H. El Hamzaoui, S. Fjouji, N. Doghmi, A. Houba, et al. (+13)
8 [GO] 2024―Mrz―18 Immunogenicity and adverse events of the COVID-19 vaccines in healthy and individuals with autoimmune diseases in an Iranian population Amin Moradi Hasan-Abad, Mohsen Arbabi, Hamidreza Gilasi, Hossein Motedayyen
9 [GO] 2023―Nov―17 Steroid initiation timing and outcome of coronavirus disease 2019 patients: A multicenter, retrospective, observational study Ryu Sugimoto, Tsuneaki Kenzaka, Ayako Mikami, Nobuaki Matsunaga, Takayuki Akiyama, Norio Ohmagari, Hogara Nishisaki
10 [GO] 2023―Okt―27 Analysis of mitochondrial function in lymphocytes obtained from COVID-19 patients Zhi He, Jing-Jing Liu, Shao-Lei Ma
11 [GO] 2023―Sep―08 Association of Guillain-Barré syndrome following COVID-19 vaccination Selia Chowdhury, Samia Chowdhury
12 [GO] 2023―Aug―03 Use of canakinumab and remdesivir in moderate-severe COVID-19 patients: A retrospective analysis Antonio Mastroianni, Valeria Vangeli, Luciana Chidichimo, Filippo Urso, Giuseppe De Marco, Alfredo Zanolini, et al. (+3)
13 [GO] 2023―Jul―03 Anti-nucleocapsid IgG antibodies in SARS-CoV-2 recovered health care workers: One year follow-up study Ashfaq Ahmad, Mohsina Haq, Asif Rehman, Najib Ul Haq
14 [GO] 2023―Jun―26 Decreased circulating CD73 and adenosine deaminase are associated with disease severity in hospitalized patients with COVID-19 Jonathan Rud, Richard R Riker, Ashley Eldridge, Christine Lord, Joanne T deKay, Teresa L May, et al. (+4)
15 [GO] 2023―Mrz―16 Patterns of cytokine and chemokine expression in peripheral blood of patients with COVID-19 associated with disease severity Iva Trifonova, Kim Ngoc, Maria Nikolova, Radoslava Emilova, Yana Todorova, Teodora Gladnishka, Iva Christova
16 [GO] 2023―Jan―17 Changes in breast cancer staging trends among Egyptian women after COVID-19: A retrospective single-center study Mostafa H Abd El Wahab, Ahmed H Ibrahim, Omar Gado, Ali M Bahbah, Waleed Fadlalla, Sherihan Fakhry, et al. (+5)
17 [GO] 2022―Dez―27 Multiple sites of thrombosis without thrombocytopenia and COVID-19 vaccine: Correspondence Rujittika Mungunpuntipantip, Viroj Wiwanitkit
18 [GO] 2022―Dez―08 Predicting roles of IL-27 and IL-32 in determining the severity and outcome of COVID-19 Batool Zamani, Maedeh Najafizadeh, Hossein Motedayyen, Reza Arefnezhad
19 [GO] 2022―Nov―29 Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies Muhammad Azeem, Ghulam Mustafa, Hafiza S Mahrosh
20 [GO] 2022―Nov―22 Epidemiological and clinical characteristics of vaccinated COVID-19 patients: A meta-analysis and systematic review Wen Tian, Xingxiang Ren, Mei Han, Yuanyuan Zhang, Xu Gao, Zhihai Chen, Wei Zhang
21 [GO] 2022―Okt―12 Blood phenotype O and indirect bilirubin are associated with lower, early COVID-19-related mortality: A retrospective study Alaa Efat, Sabry Shoeib, Ali ElKholy, Osama Saied Hussein Aboelela, Doaa Elshamy
22 [GO] 2022―Okt―10 Seroprevalence of SARS-CoV-2 antibodies in vaccinated healthcare workers in Marrakech (Morocco) Taoufik Ben Houmich, Abdelali Tali, Fayrouz Debbagh, Asma Lamrani Hanchi, Nabila Soraa
23 [GO] 2022―Okt―10 Omicron variant of SARS-CoV-2 infection elicits cross-protective immunity in people who received boosters or infected with variant strains Selia Chowdhury, Md. Shahraj Chowdhury, Nurjahan Shipa Chowdhury, Samia Chowdhury, Shajeda Chowdhury
24 [GO] 2022―Okt―07 COVID-19 diversity: A case of multisystem inflammatory syndrome in children masquerading as juvenile systemic lupus erythematosus Ali Sobh, Ashraf M Abdelrahman, Doaa Mosad Mosa
25 [GO] 2022―Sep―20 Multiple sites of thrombosis without thrombocytopenia after a second dose of Pfizer-BioNTech COVID-19 vaccine Roberto Scendoni, Cristina Petrelli, Mauro Giustozzi, Francesco O Logullo
26 [GO] 2022―Jul―16 COVID-19: Clinical laboratory diagnosis and monitoring of novel coronavirus infected patients using molecular, serological and biochemical markers: A review Ghulam Rasool, Muhammad Riaz, Mazhar Abbas, Hina Fatima, Muhammad Mustafa Qamar, Farzana Zafar, Zahed Mahmood
27 [GO] 2022―Mai―27 Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients Lamiaa A Fathalla, Lamyaa M Kamal, Omina Salaheldin, Mahmoud A Khalil, Mahmoud M Kamel, Hagar H Fahim, et al. (+4)
28 [GO] 2022―Mai―20 COVID-19 and erythrocrine function: The roller coaster and danger Hayder M Al-kuraishy, Ali I Al-Gareeb, Hope Onohuean, Gaber El-Saber Batiha
29 [GO] 2022―Mai―18 Clinical and quality of life assessment in patients with latex allergy during COVID-19 pandemic: Possible protective role of continuous latex immunotherapy Alessia Di Rienzo, Sara Urbani, David Longhino, Caterina Sarnari, Alessandro Buonomo, Angela Rizzi, et al. (+2)
30 [GO] 2022―Mai―09 IP-10 and complement activation as friend or foe in COVID-19 Saowalak Bunprakob, Pasin Hemachudha, Chanida Ruchisrisarod, Thirawat Supharatpariyakorn, Thiravat Hemachudha
31 [GO] 2022―Mrz―27 Clinical and hematological characteristics of 300 COVID-19 patients in Erbil, Kurdistan Region, Iraq Rundk Ahmad Hwaiz, Sahar Mohammed Zaki Abdullah, Salah Tofik Jalal Balaky, Katan Sabir Ali, Mohammed Yousif Merza, Shakhawan Assad Khailani, Nazar Pauls Shabila
32 [GO] 2022―Feb―03 Comparative study of six SARS-CoV-2 serology assays: Diagnostic performance and antibody dynamics in a cohort of hospitalized patients for moderate to critical COVID-19 Sameh Chamkhi, Tarak Dhaouadi, Imen Sfar, Salma Mokni, Alia Jebri, Dhouha Mansouri, et al. (+7)
33 [GO] 2021―Dez―20 Early use of canakinumab to prevent mechanical ventilation in select COVID-19 patients: A retrospective, observational analysis Antonio Mastroianni, Sonia Greco, Luciana Chidichimo, Filippo Urso, Francesca Greco, Maria V Mauro, Valeria Vangeli
34 [GO] 2021―Dez―20 Systemic corticosteroids for management of COVID-19: Saving lives or causing harm? Alireza FakhriRavari, Stephanie Jin, Farrnam H Kachouei, Diana Le, Mireya Lopez
35 [GO] 2021―Dez―20 SARS-CoV-2 tropism across the upper aerodigestive tract Sara Torretta, Lorenzo Pignataro, Paola Marchisio, Pasquale Capaccio
36 [GO] 2021―Dez―16 The COVID-19 vaccination experience in Bangladesh: Findings from a cross-sectional study Md. Rabiul Islam, Moynul Hasan, Waheeda Nasreen, Md. Ismail Tushar, Mohiuddin Ahmed Bhuiyan
37 [GO] 2021―Nov―25 Oral booster probiotic bifidobacteria in SARS-COV-2 patients Hüseyin S Bozkurt, Ömer Bilen
38 [GO] 2021―Okt―11 A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies Gabriela Athziri Sánchez-Zuno, Mónica Guadalupe Matuz-Flores, Guillermo González-Estevez, Ferdinando Nicoletti, Francisco Javier Turrubiates-Hernández, Katia Mangano, José Francisco Muñoz-Valle
39 [GO] 2021―Okt―10 Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients Peng Zhang, Wei Du, Ting Yang, Lei Zhao, Richeng Xiong, Yongqiang Li, et al. (+3)
40 [GO] 2021―Sep―27 A multicenter survey on the aspects of everyday life in adult patients with primary antibody deficiencies treated with immunoglobulin G replacement during the COVID-19 pandemic Katarzyna Napiórkowska-Baran, Tomasz Rosada, Ewa Więsik-Szewczyk, Marcin Ziętkiewicz, Aleksandra Matyja-Bednarczyk, Karolina Baranowska, et al. (+6)
41 [GO] 2021―Sep―26 A scoping review of the pathophysiology of COVID-19 Paul E Marik, Jose Iglesias, Joseph Varon, Pierre Kory
42 [GO] 2021―Sep―20 A retrospective study on the prevalence of anti-phospholipid antibodies, thrombotic events and cutaneous signs of vasculopathy in 173 hospitalized COVID-19 patients Giulia Gasparini, Paola Canepa, Simonetta Verdiani, Luca Carmisciano, Emanuele Cozzani, Denise De Grazia, et al. (+3)
43 [GO] 2021―Jul―10 The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis Monireh Golpour, Tahoora Mousavi, Mina Alimohammadi, Ali Mosayebian, Mohammadreza Shiran, Reza Alizadeh Navaei, Alireza Rafiei
44 [GO] 2021―Jun―24 Clinical features and corresponding immune function status of recurrent viral polymerase chain reaction positivity in patients with COVID-19 : A meta- analysis and systematic review Xingxiang Ren, Xiankun Wang, Ziruo Ge, Shuping Cui, Zhihai Chen
45 [GO] 2021―Jun―18 SARS-CoV-2 (COVID-19) and audio-vestibular disorders Virginia Fancello, Stavros Hatzopoulos, Virginia Corazzi, Chiara Bianchini, Magdalena B Skarżyńska, Stefano Pelucchi, et al. (+2)
46 [GO] 2020―Okt―26 The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis Hüseyin S Bozkurt, Eamonn MM Quigley
47 [GO] 2020―Okt―20 Immune system changes during COVID-19 recovery play key role in determining disease severity Farshid Fathi, Ramin Sami, Samaneh Mozafarpoor, Hossein Hafezi, Hossein Motedayyen, Reza Arefnezhad, Nahid Eskandari
48 [GO] 2020―Okt―13 Cationic drugs and COVID-19 Oreste Vittore Brenna, Sara Torretta, Lorenzo Pignataro, Federica Di Berardino
49 [GO] 2020―Aug―16 Could nasal irrigation and oral rinse reduce the risk for COVID-19 infection? Manuele Casale, Vittorio Rinaldi, Lorenzo Sabatino, Antonio Moffa, Massimo Ciccozzi
50 [GO] 2020―Jul―10 Don’t forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic! Andrea Ciorba, Virginia Corazzi, Piotr Henryk Skarżyński, Magdalena B Skarżyńska, Chiara Bianchini, Stefano Pelucchi, Stavros Hatzopoulos
 [1] 

50 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.006 sec